Louise Delsing

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.

SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.

Journal: Gene therapy

Published: November 10, 2025

Application of microphysiological systems for nonclinical evaluation of cell therapies

Application of microphysiological systems for nonclinical evaluation of cell therapies

Journal: ALTEX

Published: February 20, 2024

International evaluation study of a highly efficient culture assay for detection of residual human pluripotent stem cells in cell therapies.

International evaluation study of a highly efficient culture assay for detection of residual human pluripotent stem cells in cell therapies.

Journal: Regenerative medicine

Published: February 28, 2023

Models of the blood-brain barrier using iPSC-derived cells.

Models of the blood-brain barrier using iPSC-derived cells.

Journal: Molecular and cellular neurosciences

Published: January 27, 2020

Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.

Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.

Journal: Fluids and barriers of the CNS

Published: June 01, 2019

Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.

Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.

Journal: Advanced drug delivery reviews

Published: April 04, 2018

Plasminogen binding inhibitors demonstrate unwanted activities on GABAA and glycine receptors in human iPSC derived neurons.

Plasminogen binding inhibitors demonstrate unwanted activities on GABAA and glycine receptors in human iPSC derived neurons.

Journal: Neuroscience letters

Published: February 22, 2018

Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier.

Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier.

Journal: Stem cells (Dayton, Ohio)

Published: January 29, 2018

Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models.

Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models.

Journal: Stem cell reports

Published: July 03, 2017

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.

Journal: Neurobiology of aging

Published: January 26, 2017

Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro.

Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro.

Journal: Frontiers in molecular neuroscience

Published: November 07, 2016

Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant.

Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant.

Journal: PloS one

Published: October 03, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026